WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer models is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0.470. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Foundation for the National Institutes of Health
Grant: R01 CA82328,R35 CA197529
Japan Society for the Promotion of Science
Grant: Overseas Research Fellowships
Uehara Memorial Foundation
Grant: Research Fellowship
National Science Council
Grant: Postdoctoral Research Abroad Program Fellowship
U.S. Department of Defense
Grant: PCRP postdoctoral training award
Ministry of Education, Culture, Sports, Science and Technology
Grant: 21H02893,Grants in Aid
NCI NIH HHS
Grant: R35 CA197529
NCI NIH HHS
Grant: R01 CA082328
National Institutes of Health
Grant: 1R35CA197529-01
Targeting Tumor Suppressive Pathways for Cancer Therapy
National Institutes of Health
Grant: 5R01CA082328-15
PTEN and ontogenesis and tumor suppression
FWCI
1.18
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals